A genus in the family FILOVIRIDAE consisting of several distinct species of Ebolavirus, each containing separate strains. These viruses cause outbreaks of a contagious, hemorrhagic disease (HEMORRHAGIC FEVER, EBOLA) in humans, usually with high mortality.
A highly fatal, acute hemorrhagic fever, clinically very similar to MARBURG VIRUS DISEASE, caused by EBOLAVIRUS, first occurring in the Sudan and adjacent northwestern (what was then) Zaire.
Vaccines or candidate vaccines used to prevent EBOLA HEMORRHAGIC FEVER.
A genus in the family FILOVIRIDAE consisting of one species (Lake Victoria marburgvirus) with several strains. The genus shows no antigenic cross-reactivity with EBOLAVIRUS.
A family of RNA viruses, of the order MONONEGAVIRALES, containing filamentous virions. Although they resemble RHABDOVIRIDAE in possessing helical nucleocapsids, Filoviridae differ in the length and degree of branching in their virions. There are two genera: EBOLAVIRUS and MARBURGVIRUS.
An RNA virus infection of rhesus, vervet, and squirrel monkeys transmissible to man.
Infections with viruses of the family FILOVIRIDAE. The infections in humans consist of a variety of clinically similar viral hemorrhagic fevers but the natural reservoir host is unknown.
The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane.
A genus of the family RHABDOVIRIDAE that infects a wide range of vertebrates and invertebrates. The type species is VESICULAR STOMATITIS INDIANA VIRUS.
Disinfectant used in vapor form to sterilize vaccines, grafts, etc. The vapor is very irritating and the liquid form is carcinogenic.
An immunoglobulin fragment composed of one variable domain from an IMMUNOGLOBULIN HEAVY CHAIN or IMMUNOGLOBULIN LIGHT CHAIN.
A CELL LINE derived from the kidney of the African green (vervet) monkey, (CERCOPITHECUS AETHIOPS) used primarily in virus replication studies and plaque assays.
A large family of phosphatidylinositol phosphate-binding proteins that are involved in mediating intracellular transport and sorting of proteins via a variety of endocytic pathways.
The engulfing of liquids by cells by a process of invagination and closure of the cell membrane to form fluid-filled vacuoles.
A republic in central Africa, east of the REPUBLIC OF THE CONGO, south of the CENTRAL AFRICAN REPUBLIC and north of ANGOLA and ZAMBIA. The capital is Kinshasa.
The prevention of infection or disease following exposure to a pathogen.
A republic in west equatorial Africa, south of CAMEROON and west of the CONGO. Its capital is Libreville.
A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey (C. pygerythrus) is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research.
Vaccines using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins. They are often antigentically indistinguishable from the virus from which they were derived.
Layers of protein which surround the capsid in animal viruses with tubular nucleocapsids. The envelope consists of an inner layer of lipids and virus specified proteins also called membrane or matrix proteins. The outer layer consists of one or more types of morphological subunits called peplomers which project from the viral envelope; this layer always consists of glycoproteins.
A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala.
A broad category of viral proteins that play indirect roles in the biological processes and activities of viruses. Included here are proteins that either regulate the expression of viral genes or are involved in modifying host cell functions. Many of the proteins in this category serve multiple functions.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats.
Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.
Endocytic/exocytic CELL MEMBRANE STRUCTURES rich in glycosphingolipids, cholesterol, and lipid-anchored membrane proteins that function in ENDOCYTOSIS (potocytosis), transcytosis, and SIGNAL TRANSDUCTION. Caveolae assume various shapes from open pits to closed vesicles. Caveolar coats are composed of CAVEOLINS.
Proteins found in any species of virus.
The in vitro fusion of GENES by RECOMBINANT DNA techniques to analyze protein behavior or GENE EXPRESSION REGULATION, or to merge protein functions for specific medical or industrial uses.
'Primates' is a taxonomic order comprising various species of mammals, including humans, apes, monkeys, and others, distinguished by distinct anatomical and behavioral characteristics such as forward-facing eyes, grasping hands, and complex social structures.
Proteins conjugated with nucleic acids.
Those genes found in an organism which are necessary for its viability and normal function.
A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula.
Viral proteins found in either the NUCLEOCAPSID or the viral core (VIRAL CORE PROTEINS).
The presence of viruses in the blood.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
Specific molecular components of the cell capable of recognizing and interacting with a virus, and which, after binding it, are capable of generating some signal that initiates the chain of events leading to the biological response.
Sudden increase in the incidence of a disease. The concept includes EPIDEMICS and PANDEMICS.

Characterization of the L gene and 5' trailer region of Ebola virus. (1/581)

The nucleotide sequences of the L gene and 5' trailer region of Ebola virus strain Mayinga (subtype Zaire) have been determined, thus completing the sequence of the Ebola virus genome. The putative transcription start signal of the L gene was identical to the determined 5' terminus of the L mRNA (5' GAGGAAGAUUAA) and showed a high degree of similarity to the corresponding regions of other Ebola virus genes. The 3' end of the L mRNA terminated with 5' AUUAUAAAAAA, a sequence which is distinct from the proposed transcription termination signals of other genes. The 5' trailer sequence of the Ebola virus genomic RNA consisted of 676 nt and revealed a self-complementary sequence at the extreme end which may play an important role in virus replication. The L gene contained a single ORF encoding a polypeptide of 2212 aa. The deduced amino acid sequence showed identities of about 73 and 44% to the L proteins of Ebola virus strain Maleo (subtype Sudan) and Marburg virus, respectively. Sequence comparison studies of the Ebola virus L proteins with several corresponding proteins of other non-segmented, negative-strand RNA viruses, including Marburg viruses, confirmed a close relationship between filoviruses and members of the Paramyxovirinae. The presence of several conserved linear domains commonly found within L proteins of other members of the order Mononegavirales identified this protein as the RNA-dependent RNA polymerase of Ebola virus.  (+info)

Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells. (2/581)

Ebola virus infection is highly lethal and leads to severe immunosuppression. In this study, we demonstrate that infection of human umbilical vein endothelial cells (HUVECs) with Ebola virus Zaire (EZ) suppressed basal expression of the major histocompatibility complex class I (MHC I) family of proteins and inhibited the induction of multiple genes by alpha interferon (IFN-alpha) and IFN-gamma, including those coding for MHC I proteins, 2'-5' oligoadenylate synthetase [2'-5'(A)N], and IFN regulatory factor 1 (IRF-1). Induction of interleukin-6 (IL-6) and ICAM-1 by IL-1beta was not suppressed by infection with EZ, suggesting that the inhibition of IFN signaling is specific. Gel shift analysis demonstrated that infection with EZ blocked the induction by IFNs of nuclear proteins that bind to IFN-stimulated response elements, gamma activation sequences, and IFN regulatory factor binding site (IRF-E). In contrast, infection with EZ did not block activation of the transcription factor NF-kappaB by IL-1beta. The events that lead to the blockage of IFN signaling may be critical for Ebola virus-induced immunosuppression and would play a role in the pathogenesis of Ebola virus infection.  (+info)

Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. (3/581)

Ebola virions contain a surface transmembrane glycoprotein (GP) that is responsible for binding to target cells and subsequent fusion of the viral and host-cell membranes. GP is expressed as a single-chain precursor that is posttranslationally processed into the disulfide-linked fragments GP1 and GP2. The GP2 subunit is thought to mediate membrane fusion. A soluble fragment of the GP2 ectodomain, lacking the fusion-peptide region and the transmembrane helix, folds into a stable, highly helical structure in aqueous solution. Limited proteolysis studies identify a stable core of the GP2 ectodomain. This 74-residue core, denoted Ebo-74, was crystallized, and its x-ray structure was determined at 1.9-A resolution. Ebo-74 forms a trimer in which a long, central three-stranded coiled coil is surrounded by shorter C-terminal helices that are packed in an antiparallel orientation into hydrophobic grooves on the surface of the coiled coil. Our results confirm the previously anticipated structural similarity between the Ebola GP2 ectodomain and the core of the transmembrane subunit from oncogenic retroviruses. The Ebo-74 structure likely represents the fusion-active conformation of the protein, and its overall architecture resembles several other viral membrane-fusion proteins, including those from HIV and influenza.  (+info)

Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. (4/581)

An exhaustive epidemiologic and serologic survey was carried out in five gold-panning villages situated in northeastern Gabon to estimate the degree of exposure of to leptospirosis and Ebola virus. The seroprevalence was 15.7% for leptospirosis and 10.2% for Ebola virus. Sixty years after the last seroepidemiologic survey of leptospirosis in Gabon, this study demonstrates the persistence of this infection among the endemic population and the need to consider it as a potential cause of hemorrhagic fever in Gabon. There was no significant statistical correlation between the serologic status of populations exposed to both infectious agents, indicating the lack of common risk factors for these diseases.  (+info)

Ebola virus can be effectively neutralized by antibody produced in natural human infection. (5/581)

The activity of antibodies against filoviruses is poorly understood but has important consequences for vaccine design and passive prophylaxis. To investigate this activity, a panel of recombinant human monoclonal antibodies to Ebola virus antigens was isolated from phage display libraries constructed from RNA from donors who recovered from infection in the 1995 Ebola virus outbreak in Kikwit, Democratic Republic of Congo. Antibodies reactive with nucleoprotein (NP), envelope glycoprotein (GP), and secreted envelope glycoprotein (sGP) were characterized by immunofluorescence and radioimmunoprecipitation assays. Four antibodies reacting strongly with sGP and weakly with GP and two antibodies reacting with NP were not neutralizing. An antibody specific for GP neutralized Ebola virus to 50% at 0.4 microgram/ml as the recombinant Fab fragment and to 50% at 0.3 microgram/ml (90% at 2.6 microgram/ml) as the corresponding whole immunoglobulin G1 molecule. The studies indicate that neutralizing antibodies are produced in infection by Ebola virus although probably at a relatively low frequency. The neutralizing antibody may be useful in vaccine design and as a prophylactic agent against Ebola virus infection.  (+info)

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. (6/581)

Ebola viruses contain a single glycoprotein (GP) spike, which functions as a receptor binding and membrane fusion protein. It contains a highly conserved hydrophobic region (amino acids 524 to 539) located 24 amino acids downstream of the N terminus of the Ebola virus GP2 subunit. Comparison of this region with the structural features of the transmembrane subunit of avian retroviral GPs suggests that the conserved Ebola virus hydrophobic region may, in fact, serve as the fusion peptide. To test this hypothesis directly, we introduced conservative (alanine) and nonconservative (arginine) amino acid substitutions at eight positions in this region of the GP2 molecule. The effects of these mutations were deduced from the ability of the Ebola virus GP to complement the infectivity of a vesicular stomatitis virus (VSV) lacking the receptor-binding G protein. Some mutations, such as Ile-to-Arg substitutions at positions 532 (I532R), F535R, G536A, and P537R, almost completely abolished the ability of the GP to support VSV infectivity without affecting the transport of GP to the cell surface and its incorporation into virions or the production of virus particles. Other mutations, such as G528R, L529A, L529R, I532A, and F535A, reduced the infectivity of the VSV-Ebola virus pseudotypes by at least one-half. These findings, together with previous reports of liposome association with a peptide corresponding to positions 524 to 539 in the GP molecule, offer compelling support for a fusion peptide role for the conserved hydrophobic region in the Ebola virus GP.  (+info)

Ebola virus defective interfering particles and persistent infection. (7/581)

Ebola virus (Zaire subtype) is associated with high mortality disease outbreaks that commonly involve human to human transmission. Surviving patients can show evidence of prolonged virus persistence. The potential for Ebola virus to generate defective interfering (DI) particles and establish persistent infections in tissue culture was investigated. It was found that serial undiluted virus passages quickly resulted in production of an evolving population of virus minireplicons possessing both deletion and copyback type DI genome rearrangements. The tenth undiluted virus passage resulted in the establishment of virus persistently infected cell lines. Following one or two crises, these cells were stably maintained for several months with continuous shedding of infectious virus. An analysis of the estimated genome lengths of a selected set of the Ebola virus minireplicons and standard filoviruses revealed no obvious genome length rule, such as "the rule of six" found for the phylogenetically related Paramyxovirinae subfamily viruses. Minimal promoters for Ebola virus replication were found to be contained within 156 and 177 nucleotide regions of the genomic and antigenomic RNA 3' termini, respectively, based on the length of authentic termini retained in the naturally occurring minireplicons analyzed. In addition, using UV-irradiated preparations of virus released from persistently infected cells, it was demonstrated that Ebola virus DI particles could potentially be used as natural minireplicons to assay standard virus support functions.  (+info)

Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus. (8/581)

In the present study we have investigated processing and maturation of the nonstructural small glycoprotein (sGP) of Ebola virus. When sGP expressed from vaccinia virus vectors was analyzed by pulse-chase experiments using SDS-PAGE under reducing conditions, the mature form and two different precursors have been identified. First, the endoplasmic reticulum form sGP(er), full-length sGP with oligomannosidic N-glycans, was detected, sGP(er) was then replaced by the Golgi-specific precursor pre-sGP, full-length sGP containing complex N-glycans. This precursor was finally converted by proteolysis into mature sGP and a smaller cleavage fragment, Delta-peptide. Studies employing site-directed mutagenesis revealed that sGP was cleaved at a multibasic amino acid motif at positions 321 to 324 of the open reading frame. Cleavage was blocked by RVKR-chloromethyl ketone. Uncleaved pre-sGP forms a disulfide-linked homodimer and is secreted into the culture medium in the presence of the inhibitor as efficiently as proteolytically processed sGP. In vitro treatment of pre-sGP by purified recombinant furin resulted in efficient cleavage, confirming the importance of this proprotein convertase for the processing and maturation of sGP. Delta-peptide is also secreted into the culture medium and therefore represents a novel nonstructural expression product of the GP gene of Ebola virus. Both cleavage fragments contain sialic acid, but only Delta-peptide is highly O-glycosylated.  (+info)

Ebolavirus is a genus of viruses in the family Filoviridae, order Mononegavirales. It is named after the Ebola River in the Democratic Republic of Congo (formerly Zaire), where the virus was first identified in 1976. There are six species of Ebolavirus, four of which are known to cause disease in humans: Zaire ebolavirus, Sudan ebolavirus, Bundibugyo ebolavirus, and Tai Forest ebolavirus (formerly Cote d'Ivoire ebolavirus). The fifth species, Reston ebolavirus, is known to cause disease in non-human primates and pigs, but not in humans. The sixth and most recently identified species, Bombali ebolavirus, has not been associated with any human or animal diseases.

Ebolaviruses are enveloped, negative-sense, single-stranded RNA viruses that cause a severe and often fatal hemorrhagic fever in humans and non-human primates. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. Fruit bats of the Pteropodidae family are considered to be the natural host of Ebolavirus.

The symptoms of Ebolavirus disease (EVD) typically include fever, severe headache, muscle pain, weakness, fatigue, and sore throat, followed by vomiting, diarrhea, rash, impaired kidney and liver function, and in some cases, both internal and external bleeding. The case fatality rate of EVD is variable but has been historically high, ranging from 25% to 90% in past outbreaks depending on the species and the quality of medical care. There are no licensed specific treatments or vaccines available for EVD, although several promising candidates are currently under development.

Ebola Hemorrhagic Fever (EHF) is a severe, often fatal illness in humans. It is one of the five identified subtypes of the Ebolavirus. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.

The early symptoms include sudden onset of fever, fatigue, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, symptoms of impaired kidney and liver function, and in some cases, both internal and external bleeding.

Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes.

The virus is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals such as fruit bats, porcupines and non-human primates. Then it spreads in communities through human-to-human transmission via direct contact (through broken skin or mucous membranes) with the blood, secretions, organs or other bodily fluids of infected people, and with surfaces and materials contaminated with these fluids.

Healthcare workers have frequently been infected while treating patients with suspected or confirmed EVD due to a lack of adequate infection prevention and control measures.

There are currently no approved specific antiviral drugs or vaccines for Ebola. Several promising treatments and vaccine candidates are being evaluated.

Ebola vaccines are medical products designed to confer immunity against the Ebola virus, a deadly pathogen that causes hemorrhagic fever. Several Ebola vaccine candidates have been developed and tested in clinical trials, with some showing promising results. The most advanced Ebola vaccine is rVSV-ZEBOV, which has been shown to be highly effective in preventing the disease in clinical trials. It uses a weakened version of the vesicular stomatitis virus (VSV) to deliver a protein from the Ebola virus surface, triggering an immune response that protects against infection. Other Ebola vaccine candidates use different approaches, such as delivering Ebola virus genes using a harmless adenovirus vector or using inactivated whole Ebola viruses. These vaccines are still in development and have not yet been approved for widespread use.

According to the World Health Organization (WHO), Marburgviruses are toxiviral hemorrhagic fever-causing agents that belong to the Filoviridae family, which also includes Ebolaviruses. These enveloped, non-segmented, negative-stranded RNA viruses cause a severe and often fatal illness in humans and non-human primates. The Marburg virus was initially discovered in 1967, after simultaneous outbreaks occurred in laboratories in Marburg and Frankfurt, Germany, and in Belgrade, Yugoslavia (now Serbia).

The virions of Marburgviruses are typically filamentous or U-shaped and measure approximately 80 nm in diameter. The genome consists of a single non-segmented, negative-sense RNA molecule that encodes seven structural proteins: nucleoprotein (NP), polymerase cofactor protein (VP35), matrix protein (VP40), glycoprotein (GP), transcription activator protein (VP30), RNA-dependent RNA polymerase (L), and a small hydrophobic protein (sVP24 or VP80).

Marburgviruses are primarily transmitted to humans through contact with the bodily fluids of infected animals, such as bats and non-human primates. Human-to-human transmission can occur via direct contact with infected individuals' blood, secretions, organs, or other bodily fluids, as well as through contaminated surfaces and materials.

The incubation period for Marburg virus disease (MVD) typically ranges from 2 to 21 days. Initial symptoms include fever, chills, headache, muscle aches, and general malaise. As the disease progresses, patients may develop severe watery diarrhea, abdominal pain, nausea, vomiting, and unexplained bleeding or bruising. In fatal cases, MVD can cause multi-organ failure, shock, and death, often within 7 to 14 days after symptom onset.

Currently, there are no approved vaccines or antiviral treatments specifically for Marburg virus infections. However, supportive care, such as fluid replacement, electrolyte management, and treatment of secondary infections, can help improve outcomes for MVD patients. Preventive measures, including the use of personal protective equipment (PPE) and proper infection control practices, are crucial to reducing the risk of transmission during outbreaks.

Filoviridae is a family of negative-sense, single-stranded RNA viruses that includes three genera: Ebolavirus, Marburgvirus, and Cuevavirus. These viruses are known to cause severe hemorrhagic fever in humans and nonhuman primates, with high fatality rates. The most well-known members of this family are Ebola virus and Marburg virus.

The virions of Filoviridae are filamentous, often having a "U," "6," or "hook" shape, and can be up to 14,000 nanometers in length. The genome of these viruses is non-segmented and contains seven genes that encode for structural proteins and enzymes necessary for replication.

Transmission of Filoviridae occurs through direct contact with infected bodily fluids or contaminated surfaces, and infection can result in a range of symptoms including fever, severe headache, muscle pain, weakness, fatigue, and hemorrhage. There are currently no approved vaccines or antiviral treatments for Filoviridae infections, although several are in development.

Marburg Virus Disease (MVD) is an acute and often fatal viral hemorrhagic fever illness caused by the Marburg virus, a member of the filovirus family. It's a highly infectious disease that can be transmitted from human to human through direct contact with infected bodily fluids, tissues, or indirectly through contaminated surfaces and materials.

The incubation period for MVD ranges from 2 to 21 days, after which symptoms such as fever, chills, headache, muscle aches, severe malaise, and progressive weakness appear. Around the fifth day of illness, a maculopapular rash may occur, followed by diarrhea, nausea, vomiting, abdominal pain, and non-bloody stools. In some cases, patients may develop severe bleeding disorders, shock, liver failure, and multi-organ dysfunction, which can lead to death in 24-48 hours.

Currently, there are no approved vaccines or antiviral treatments for MVD, but supportive care is crucial for managing the symptoms of the disease. Preventive measures such as avoiding contact with infected individuals and their bodily fluids, wearing protective clothing, and practicing good hygiene can help prevent the spread of the virus.

Filoviridae infections refer to diseases caused by viruses belonging to the Filoviridae family, which includes Ebola virus and Marburg virus. These viruses are characterized by filamentous or threadlike shapes and can cause severe hemorrhagic fever in humans and primates. The infections are associated with high mortality rates, ranging from 25% to 90%, depending on the specific virus and strain.

Transmission of Filoviridae viruses occurs through direct contact with infected bodily fluids or contaminated surfaces. The initial symptoms of infection include fever, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and impaired organ function. In severe cases, the disease can progress to hemorrhagic fever, characterized by internal and external bleeding, shock, and multi-organ failure.

Currently, there are no approved vaccines or antiviral treatments for Filoviridae infections, although several experimental therapies and vaccines are under development. Prevention measures include avoiding contact with infected individuals, practicing good hygiene, and using personal protective equipment when caring for sick patients.

Virus internalization, also known as viral entry, is the process by which a virus enters a host cell to infect it and replicate its genetic material. This process typically involves several steps:

1. Attachment: The viral envelope proteins bind to specific receptors on the surface of the host cell.
2. Entry: The virus then enters the host cell through endocytosis or membrane fusion, depending on the type of virus.
3. Uncoating: Once inside the host cell, the viral capsid is removed, releasing the viral genome into the cytoplasm.
4. Replication: The viral genome then uses the host cell's machinery to replicate itself and produce new viral particles.

It's important to note that the specific mechanisms of virus internalization can vary widely between different types of viruses, and are an active area of research in virology and infectious disease.

Vesiculovirus is a genus of enveloped, negative-stranded RNA viruses in the family Rhabdoviridae. They are known to cause vesicular diseases (hence the name) in both animals and humans, characterized by the formation of blisters or vesicles on the skin. The most well-known member of this genus is the vesicular stomatitis virus (VSV), which primarily affects cattle, horses, and pigs, causing oral and foot lesions. However, VSV can also infect humans, resulting in a flu-like illness. Other members of the Vesiculovirus genus include the Isfahan virus, Chandipura virus, and the Piry virus. These viruses are transmitted through insect vectors such as mosquitoes and sandflies, and can cause significant economic losses in the agricultural industry.

I'm sorry for any confusion, but "Propiolactone" is not a medical term. It is a chemical compound with the formula CH2CHCO2H. It is also known as propionic acid lactone or 3-hydroxypropanoic acid. It is used in various industrial applications such as a solvent, plasticizer, and an intermediate in organic synthesis.

However, if you are looking for a medical definition related to the topic of lactones, I can provide that:

Lactones are chemical compounds that contain a cyclic ester structure. They are formed by the reaction between a carboxylic acid and an alcohol, resulting in the elimination of a molecule of water. Lactones can be found naturally in some foods and plants, and they also have various industrial applications.

In a medical context, lactones may refer to certain medications or chemical compounds that contain a lactone ring structure. For example, penicillin is an antibiotic that contains a beta-lactam ring, which is a type of lactone. These types of medications can cause allergic reactions in some people, particularly those with a history of allergies to penicillin or other beta-lactam antibiotics.

Single-domain antibodies (sdAbs), also known as nanobodies or VHHs, are antigen-binding fragments derived from the heavy-chain only antibodies found in camelids (camels, llamas, and alpacas) and some shark species. These unique antibodies lack light chains and consist of a single variable domain (VHH) that can bind to specific antigens with high affinity and stability. The small size (12-15 kDa), robustness, and solubility make sdAbs attractive for various biotechnological and therapeutic applications, including diagnostics, targeted drug delivery, and protein engineering.

Vero cells are a line of cultured kidney epithelial cells that were isolated from an African green monkey (Cercopithecus aethiops) in the 1960s. They are named after the location where they were initially developed, the Vervet Research Institute in Japan.

Vero cells have the ability to divide indefinitely under certain laboratory conditions and are often used in scientific research, including virology, as a host cell for viruses to replicate. This allows researchers to study the characteristics of various viruses, such as their growth patterns and interactions with host cells. Vero cells are also used in the production of some vaccines, including those for rabies, polio, and Japanese encephalitis.

It is important to note that while Vero cells have been widely used in research and vaccine production, they can still have variations between different cell lines due to factors like passage number or culture conditions. Therefore, it's essential to specify the exact source and condition of Vero cells when reporting experimental results.

Sorting nexins are a group of proteins that are involved in the intracellular trafficking and sorting of membrane-bound organelles and vesicles. They were first identified by their ability to bind to small GTPases of the Rab family, which are important regulators of vesicle transport. Sorting nexins contain a phox (PX) domain that binds to phosphatidylinositol 3-phosphate (PI3P), a lipid found on early endosomes, and a Bin/Amphyphysin/Rvs (BAR) domain that can sense and shape membranes.

Sorting nexins have been implicated in various cellular processes, including the sorting of receptors and ligands in the endocytic pathway, the regulation of autophagy, and the maintenance of Golgi apparatus structure and function. Mutations in sorting nexin genes have been associated with several human diseases, such as Parkinson's disease, hereditary spastic paraplegia, and cancer.

In summary, sorting nexins are a family of proteins that play crucial roles in intracellular membrane trafficking and sorting by interacting with Rab GTPases, phosphoinositides, and membranes through their PX and BAR domains.

Pinocytosis is a type of cellular process involving the ingestion and absorption of extracellular fluid and dissolved substances into a cell. It is a form of endocytosis, where the cell membrane surrounds and engulfs the extracellular fluid to form a vesicle containing the fluid and its contents within the cell cytoplasm.

In pinocytosis, the cell membrane invaginates and forms small vesicles (pinocytotic vesicles) that contain extracellular fluid and dissolved substances. These vesicles then detach from the cell membrane and move into the cytoplasm, where they fuse with endosomes or lysosomes to break down and digest the contents of the vesicle.

Pinocytosis is a non-selective process that allows cells to take up small amounts of extracellular fluid and dissolved substances from their environment. It plays an important role in various physiological processes, including nutrient uptake, cell signaling, and the regulation of extracellular matrix composition.

The Democratic Republic of the Congo (DRC) is a country located in Central Africa. It is named after the Congo River, which flows through the country. The DRC is the second-largest country in Africa by area and the eleventh-largest in the world. It is home to a diverse population of more than 80 million people, making it one of the most populous countries on the continent.

The DRC is a democratic republic, which means that it is a form of government in which the people have the power to choose their leaders through free and fair elections. The country has a presidential system of government, in which the president serves as both the head of state and the head of government. The current president of the DRC is Félix Tshisekedi, who took office in January 2019.

The DRC is a federal republic, meaning that it is divided into several provinces, each with its own elected government. The country has a total of 26 provinces, which are further divided into districts and sectors.

The DRC is a member of various international organizations, including the United Nations, the African Union, and the Southern African Development Community. It is also a party to several international treaties and agreements, such as the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and the Paris Agreement on climate change.

The DRC has a mixed economy, with both private and public sectors playing important roles. The country is rich in natural resources, including minerals such as copper, diamonds, gold, and tin. It also has large areas of fertile land that are suitable for agriculture. However, the DRC faces significant challenges, including poverty, corruption, and conflict. Despite these challenges, the country has made progress in recent years in terms of economic growth and development.

Post-exposure prophylaxis (PEP) is the medical practice of using antiviral medications to prevent the development of a disease after an exposure to that disease. It is most commonly used in the context of preventing HIV infection, where it involves taking a combination of antiretroviral drugs for 28 days following potential exposure to the virus, such as through sexual assault or accidental needlestick injuries.

The goal of PEP is to reduce the risk of HIV infection by stopping the virus from replicating and establishing itself in the body. However, it is not 100% effective and should be used in conjunction with other preventative measures such as safe sex practices and proper use of personal protective equipment.

It's important to note that PEP must be started as soon as possible after exposure, ideally within 72 hours, but preferably within 24 hours, for it to be most effective. The decision to initiate PEP should be made in consultation with a medical professional and will depend on various factors such as the type of exposure, the risk of transmission, and the individual's medical history.

I'm sorry for any confusion, but "Gabon" is not a medical term. It is the name of a country located in Central Africa, known officially as the Gabonese Republic. If you have any questions about medical terminology or health-related topics, I would be happy to help with those!

'Cercopithecus aethiops' is the scientific name for the monkey species more commonly known as the green monkey. It belongs to the family Cercopithecidae and is native to western Africa. The green monkey is omnivorous, with a diet that includes fruits, nuts, seeds, insects, and small vertebrates. They are known for their distinctive greenish-brown fur and long tail. Green monkeys are also important animal models in biomedical research due to their susceptibility to certain diseases, such as SIV (simian immunodeficiency virus), which is closely related to HIV.

Virus-like particles (VLPs) are nanostructures that mimic the organization and conformation of authentic viruses but lack the genetic material required for replication. VLPs can be produced from one or more viral proteins, which can be derived from various expression systems including bacteria, yeast, insect, or mammalian cells.

VLP-based vaccines are a type of vaccine that uses these virus-like particles to induce an immune response in the body. These vaccines can be designed to target specific viruses or other pathogens and have been shown to be safe and effective in inducing both humoral and cellular immunity.

VLPs resemble authentic viruses in their structure, size, and antigenic properties, making them highly immunogenic. They can be designed to present specific epitopes or antigens from a pathogen, which can stimulate the immune system to produce antibodies and activate T-cells that recognize and attack the pathogen.

VLP vaccines have been developed for several viruses, including human papillomavirus (HPV), hepatitis B virus (HBV), and respiratory syncytial virus (RSV). They offer several advantages over traditional vaccines, such as a strong immune response, safety, and stability.

Viral envelope proteins are structural proteins found in the envelope that surrounds many types of viruses. These proteins play a crucial role in the virus's life cycle, including attachment to host cells, fusion with the cell membrane, and entry into the host cell. They are typically made up of glycoproteins and are often responsible for eliciting an immune response in the host organism. The exact structure and function of viral envelope proteins vary between different types of viruses.

I'm sorry for any confusion, but "Uganda" is not a medical term or concept. It is the name of a country located in East Africa, known officially as the Republic of Uganda. If you have any questions about medical terms or concepts, I would be happy to help with those!

Viral regulatory and accessory proteins are a type of viral protein that play a role in the regulation of viral replication, gene expression, and host immune response. These proteins are not directly involved in the structural components of the virus but instead help to modulate the environment inside the host cell to facilitate viral replication and evade the host's immune system.

Regulatory proteins control various stages of the viral life cycle, such as transcription, translation, and genome replication. They may also interact with host cell regulatory proteins to alter their function and promote viral replication. Accessory proteins, on the other hand, are non-essential for viral replication but can enhance viral pathogenesis or modulate the host's immune response.

The specific functions of viral regulatory and accessory proteins vary widely among different viruses. For example, in human immunodeficiency virus (HIV), the Tat protein is a regulatory protein that activates transcription of the viral genome, while the Vpu protein is an accessory protein that downregulates the expression of CD4 receptors on host cells to prevent superinfection.

Understanding the functions of viral regulatory and accessory proteins is important for developing antiviral therapies and vaccines, as these proteins can be potential targets for inhibiting viral replication or modulating the host's immune response.

Antibodies, viral are proteins produced by the immune system in response to an infection with a virus. These antibodies are capable of recognizing and binding to specific antigens on the surface of the virus, which helps to neutralize or destroy the virus and prevent its replication. Once produced, these antibodies can provide immunity against future infections with the same virus.

Viral antibodies are typically composed of four polypeptide chains - two heavy chains and two light chains - that are held together by disulfide bonds. The binding site for the antigen is located at the tip of the Y-shaped structure, formed by the variable regions of the heavy and light chains.

There are five classes of antibodies in humans: IgA, IgD, IgE, IgG, and IgM. Each class has a different function and is distributed differently throughout the body. For example, IgG is the most common type of antibody found in the bloodstream and provides long-term immunity against viruses, while IgA is found primarily in mucous membranes and helps to protect against respiratory and gastrointestinal infections.

In addition to their role in the immune response, viral antibodies can also be used as diagnostic tools to detect the presence of a specific virus in a patient's blood or other bodily fluids.

Chiroptera is the scientific order that includes all bat species. Bats are the only mammals capable of sustained flight, and they are distributed worldwide with the exception of extremely cold environments. They vary greatly in size, from the bumblebee bat, which weighs less than a penny, to the giant golden-crowned flying fox, which has a wingspan of up to 6 feet.

Bats play a crucial role in many ecosystems as pollinators and seed dispersers for plants, and they also help control insect populations. Some bat species are nocturnal and use echolocation to navigate and find food, while others are diurnal and rely on their vision. Their diet mainly consists of insects, fruits, nectar, and pollen, although a few species feed on blood or small vertebrates.

Unfortunately, many bat populations face significant threats due to habitat loss, disease, and wind turbine collisions, leading to declining numbers and increased conservation efforts.

Humoral immunity is a type of immune response in which the body produces proteins called antibodies that circulate in bodily fluids such as blood and help to protect against infection. This form of immunity involves the interaction between antigens (foreign substances that trigger an immune response) and soluble factors, including antibodies, complement proteins, and cytokines.

When a pathogen enters the body, it is recognized as foreign by the immune system, which triggers the production of specific antibodies to bind to and neutralize or destroy the pathogen. These antibodies are produced by B cells, a type of white blood cell that is part of the adaptive immune system.

Humoral immunity provides protection against extracellular pathogens, such as bacteria and viruses, that exist outside of host cells. It is an important component of the body's defense mechanisms and plays a critical role in preventing and fighting off infections.

Caveolae are small, flask-shaped invaginations of the plasma membrane that are abundant in many cell types, including endothelial cells, adipocytes, and muscle cells. They are characterized by the presence of caveolin proteins, which play a crucial role in their formation and function.

Caveolae have been implicated in various cellular processes, such as endocytosis, signal transduction, cholesterol homeostasis, and mechanoprotection. They can also serve as platforms for the assembly of signaling complexes and the regulation of various enzymatic activities.

The invaginated structure of caveolae allows them to interact with extracellular molecules and intracellular proteins, facilitating the exchange of materials between the plasma membrane and the cytosol. Dysregulation of caveolae function has been linked to several diseases, including cardiovascular disorders, cancer, and neurological conditions.

Viral proteins are the proteins that are encoded by the viral genome and are essential for the viral life cycle. These proteins can be structural or non-structural and play various roles in the virus's replication, infection, and assembly process. Structural proteins make up the physical structure of the virus, including the capsid (the protein shell that surrounds the viral genome) and any envelope proteins (that may be present on enveloped viruses). Non-structural proteins are involved in the replication of the viral genome and modulation of the host cell environment to favor viral replication. Overall, a thorough understanding of viral proteins is crucial for developing antiviral therapies and vaccines.

Artificial gene fusion refers to the creation of a new gene by joining together parts or whole sequences from two or more different genes. This is achieved through genetic engineering techniques, where the DNA segments are cut and pasted using enzymes called restriction endonucleases and ligases. The resulting artificial gene may encode for a novel protein with unique functions that neither of the parental genes possess. This approach has been widely used in biomedical research to study gene function, create new diagnostic tools, and develop gene therapies.

In a medical or scientific context, "Primates" is a biological order that includes various species of mammals, such as humans, apes, monkeys, and prosimians (like lemurs and lorises). This group is characterized by several distinct features, including:

1. A forward-facing eye position, which provides stereoscopic vision and depth perception.
2. Nails instead of claws on most digits, except for the big toe in some species.
3. A rotating shoulder joint that allows for a wide range of motion in the arms.
4. A complex brain with a well-developed cortex, which is associated with higher cognitive functions like problem-solving and learning.
5. Social structures and behaviors, such as living in groups and exhibiting various forms of communication.

Understanding primates is essential for medical and biological research since many human traits, diseases, and behaviors have their origins within this group.

Nucleoproteins are complexes formed by the association of proteins with nucleic acids (DNA or RNA). These complexes play crucial roles in various biological processes, such as packaging and protecting genetic material, regulating gene expression, and replication and repair of DNA. In these complexes, proteins interact with nucleic acids through electrostatic, hydrogen bonding, and other non-covalent interactions, leading to the formation of stable structures that help maintain the integrity and function of the genetic material. Some well-known examples of nucleoproteins include histones, which are involved in DNA packaging in eukaryotic cells, and reverse transcriptase, an enzyme found in retroviruses that transcribes RNA into DNA.

"Essential genes" refer to a category of genes that are vital for the survival or reproduction of an organism. They encode proteins that are necessary for fundamental biological processes, such as DNA replication, transcription, translation, and cell division. Mutations in essential genes often result in lethality or infertility, making them indispensable for the organism's existence. The identification and study of essential genes can provide valuable insights into the basic mechanisms of life and disease.

"Macaca fascicularis" is the scientific name for the crab-eating macaque, also known as the long-tailed macaque. It's a species of monkey that is native to Southeast Asia. They are called "crab-eating" macaques because they are known to eat crabs and other crustaceans. These monkeys are omnivorous and their diet also includes fruits, seeds, insects, and occasionally smaller vertebrates.

Crab-eating macaques are highly adaptable and can be found in a wide range of habitats, including forests, grasslands, and wetlands. They are also known to live in close proximity to human settlements and are often considered pests due to their tendency to raid crops and steal food from humans.

These monkeys are social animals and live in large groups called troops. They have a complex social structure with a clear hierarchy and dominant males. Crab-eating macaques are also known for their intelligence and problem-solving abilities.

In medical research, crab-eating macaques are often used as animal models due to their close genetic relationship to humans. They are used in studies related to infectious diseases, neuroscience, and reproductive biology, among others.

Nucleocapsid proteins are structural proteins that are associated with the viral genome in many viruses. They play a crucial role in the formation and stability of the viral particle, also known as the virion. In particular, nucleocapsid proteins bind to the viral RNA or DNA genome and help to protect it from degradation by host cell enzymes. They also participate in the assembly and disassembly of the virion during the viral replication cycle.

In some viruses, such as coronaviruses, the nucleocapsid protein is also involved in regulating the transcription and replication of the viral genome. The nucleocapsid protein of SARS-CoV-2, for example, has been shown to interact with host cell proteins that are involved in the regulation of gene expression, which may contribute to the virus's ability to manipulate the host cell environment and evade the immune response.

Overall, nucleocapsid proteins are important components of many viruses and are often targeted by antiviral therapies due to their essential role in the viral replication cycle.

Viremia is a medical term that refers to the presence of viruses in the bloodstream. It occurs when a virus successfully infects a host and replicates within the body's cells, releasing new viral particles into the blood. This condition can lead to various clinical manifestations depending on the specific virus involved and the immune response of the infected individual. Some viral infections result in asymptomatic viremia, while others can cause severe illness or even life-threatening conditions. The detection of viremia is crucial for diagnosing certain viral infections and monitoring disease progression or treatment effectiveness.

Virus replication is the process by which a virus produces copies or reproduces itself inside a host cell. This involves several steps:

1. Attachment: The virus attaches to a specific receptor on the surface of the host cell.
2. Penetration: The viral genetic material enters the host cell, either by invagination of the cell membrane or endocytosis.
3. Uncoating: The viral genetic material is released from its protective coat (capsid) inside the host cell.
4. Replication: The viral genetic material uses the host cell's machinery to produce new viral components, such as proteins and nucleic acids.
5. Assembly: The newly synthesized viral components are assembled into new virus particles.
6. Release: The newly formed viruses are released from the host cell, often through lysis (breaking) of the cell membrane or by budding off the cell membrane.

The specific mechanisms and details of virus replication can vary depending on the type of virus. Some viruses, such as DNA viruses, use the host cell's DNA polymerase to replicate their genetic material, while others, such as RNA viruses, use their own RNA-dependent RNA polymerase or reverse transcriptase enzymes. Understanding the process of virus replication is important for developing antiviral therapies and vaccines.

Virus receptors are specific molecules (commonly proteins) on the surface of host cells that viruses bind to in order to enter and infect those cells. This interaction between the virus and its receptor is a critical step in the infection process. Different types of viruses have different receptor requirements, and identifying these receptors can provide important insights into the biology of the virus and potential targets for antiviral therapies.

A disease outbreak is defined as the occurrence of cases of a disease in excess of what would normally be expected in a given time and place. It may affect a small and localized group or a large number of people spread over a wide area, even internationally. An outbreak may be caused by a new agent, a change in the agent's virulence or host susceptibility, or an increase in the size or density of the host population.

Outbreaks can have significant public health and economic impacts, and require prompt investigation and control measures to prevent further spread of the disease. The investigation typically involves identifying the source of the outbreak, determining the mode of transmission, and implementing measures to interrupt the chain of infection. This may include vaccination, isolation or quarantine, and education of the public about the risks and prevention strategies.

Examples of disease outbreaks include foodborne illnesses linked to contaminated food or water, respiratory infections spread through coughing and sneezing, and mosquito-borne diseases such as Zika virus and West Nile virus. Outbreaks can also occur in healthcare settings, such as hospitals and nursing homes, where vulnerable populations may be at increased risk of infection.

Sudan ebolavirus, Taï Forest ebolavirus (originally Côte d'Ivoire ebolavirus), Zaire ebolavirus, and Bombali ebolavirus. The ... Each species of the genus Ebolavirus has one member virus, and four of these cause Ebola virus disease (EVD) in humans, a type ... The genus Ebolavirus (/iˈboʊlə/- or /əˈboʊləˌvaɪrəs/; ee-BOH-lə- or ə-BOH-lə-VY-rəs) is a virological taxon included in the ... The name Ebolavirus is derived from the Ebola River in Zaire (now the Democratic Republic of the Congo), near the location of ...
Ebola virus is the single member of the species Zaire ebolavirus, which is assigned to the genus Ebolavirus, family Filoviridae ... The name Zaire ebolavirus is derived from Zaire and the taxonomic suffix ebolavirus (which denotes an ebolavirus species and ... However, most scientific articles continued to refer to "Ebola virus" or used the terms "Ebola virus" and "Zaire ebolavirus" in ... Wikimedia Commons has media related to Ebolavirus. Ebolavirus molecular biology Ebolavirus proteins (PDB-101) ICTV Files and ...
In 2002, the name was changed to Sudan ebolavirus. A virus of the genus Ebolavirus is a member of the species Sudan ebolavirus ... and the taxonomic suffix ebolavirus (which denotes an ebolavirus species). The species was introduced in 1998 as Sudan Ebola ... The species Sudan ebolavirus is a virological taxon included in the genus Ebolavirus, family Filoviridae, order Mononegavirales ... The name Sudan ebolavirus is derived from Sudan (the country in which Sudan virus was first discovered) ...
... or Bombali virus (BOMV) is a species of the genus Ebolavirus, first reported on 27 July 2018. It was ... The team reporting the virus also published its full genome sequence (NC_039345). Zaire ebolavirus "Genus: Ebolavirus" (html). ... Bombali ebolavirus has the capacity to infect human cells, although it has not yet been shown to be pathogenic. ... "New Ebola virus strain found in Sierra Leone". reliefweb.int. Retrieved 27 July 2018. Rosenbaum, Leah (27 July 2018). "A new ...
In 2002, the name was changed to Cote d'Ivoire ebolavirus. The name was proposed to be changed to Taï Forest ebolavirus in 2010 ... The species Taï Forest ebolavirus (/tɑːˈiː/) is a virological taxon included in the genus Ebolavirus, family Filoviridae, order ... A virus of the genus Ebolavirus is a member of the species Taï Forest ebolavirus if: it is endemic in Côte d'Ivoire it has a ... and the taxonomic suffix ebolavirus (which denotes an ebolavirus species). According to the rules for taxon naming established ...
Ebola virus epidemic in West Africa List of Ebola outbreaks Carod-Artal FJ (3 October 2015). "Post-Ebolavirus disease syndrome ... 2017). "Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection". ... 2017). "Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection". ... PREVAIL VII examined if survivors of Ebola virus disease had evidence of Ebola virus RNA in aqueous humor and outcomes of ...
Health in Mali Ebola virus epidemic in West Africa Ebola virus epidemic in Guinea Ebola virus epidemic in Liberia Ebola virus ... Ebola virus disease in Mali occurred in October 2014, leading to concern about the possibility of an outbreak of Ebola in Mali ... "WHO , Ebola virus disease - Mali". November 2, 2014. Archived from the original on 2014-11-02. "Mali remains 'free' of deadly ... Ebola virus disease - Mali Mali case, Ebola imported from Guinea Mali Government website Mali Situation Report "Ebola outbreak ...
"Five Ebola virus patients in DR Congo reported dead: WHO". BERNAMA. 25 May 2022. Retrieved 13 June 2022. "5 Ebola virus ... "Ebola virus disease". Retrieved 15 August 2014. King JW (2 April 2008). "Ebola Virus". eMedicine. WebMD. Retrieved 6 October ... "Democratic Republic of the Congo Ebola virus" (PDF). World Health Organization. Retrieved 22 May 2018. "Ebola virus disease - ... Viruses portal West African Ebola virus epidemic Ebola virus Hewlett, Barry; Hewlett, Bonnie (2007). Ebola, Culture and ...
Ebola vaccine Ebola virus epidemic in West Africa Choi JH, Croyle MA (December 2013). "Emerging targets and novel approaches to ... "Ebola Virus Disease (EVD) Information for Clinicians in U.S. Healthcare Settings". Centers for Disease Control and Prevention ( ... July 2016). "Ebola virus disease and critical illness". Critical Care. 20 (1): 217. doi:10.1186/s13054-016-1325-2. PMC 4965892 ... On 29 March 2015, a new rapid Ebola virus diagnostic kit/test was developed by British military scientists and NHS in Sierra ...
Ebola virus epidemic in West Africa Ebola virus epidemic in Guinea Ebola virus epidemic in Sierra Leone Ebola virus disease in ... The Ebola virus, a biosafety level four pathogen, is an RNA virus discovered in 1976. Before the outbreak of the Ebola epidemic ... An epidemic of Ebola virus disease occurred in Liberia from 2014 to 2015, along with the neighbouring countries of Guinea and ... By 2 July a third new case was confirmed leading to the possibility that they might have been infected with the Ebola virus ...
... could mean: 2018 Équateur province Ebola outbreak 2018 Kivu Ebola outbreak This disambiguation ... page lists articles associated with the title 2018 DRC Ebola virus outbreak. If an internal link led you here, you may wish to ...
In 2014, Ebola virus disease in Spain occurred due to two patients with cases of the disease contracted during the Ebola virus ... "Spanish researchers develop five-strain vaccine against lethal Ebola virus". 2018-07-12. "Vaccine for killer Ebola virus being ... A failure in infection control in the treatment of the second patient led to an isolated infection of Ebola virus disease in a ... It was reported on October 17 that all the other people suspected of being infected in Spain had tested negative for the Ebola virus ...
Thus Ebola virus disease spread for several months before it was recognized as such. In late October 2014, the child was ... Feb 1999). "Ebola Virus Outbreak among Wild Chimpanzees Living in a Rain Forest of Côte d'Ivoire". J. Infect. Dis. 179 (s1): ... "Ebola virus disease, West Africa (Update of 26 May 2014)". Afro.who.int. Archived from the original on 29 July 2014. Retrieved ... "Ebola virus death toll in West Africa passes 1,000". News.com.au. 12 August 2014. Retrieved 25 October 2014. "Ebola death toll ...
... has occurred rarely in four cases to date, namely three health workers returning from ... "Outbreaks Chronology: Ebola Virus Disease". CDC. 17 July 2019. "British Ebola patient arrives in UK for hospital treatment". ... "Ebola: outbreak of Sudan ebolavirus in Uganda". GOV.UK. 6 October 2022. Retrieved 9 December 2022. "How the UK government is ... In October 2015, Cafferkey was diagnosed with late complications caused by the Ebola virus hitherto considered unusual, and ...
Ebola virus epidemic in Guinea Ebola virus epidemic in Liberia Ebola virus epidemic in Nigeria Ebola virus epidemic in Sierra ... However, he died at 7:51 a.m. on October 8, becoming the first person to die in the United States of Ebola virus disease and ... By the time the Ebola virus epidemic in West Africa was over in June 2016, seven Americans had been evacuated to the U.S. for ... A second set of teams will prep hospitals in cities deemed most likely to see an Ebola virus case. Three of those teams are ...
"Five Ebola virus patients in DR Congo reported dead: WHO". BERNAMA. 25 May 2022. Retrieved 13 June 2022. "5 Ebola virus ... "Democratic Republic of the Congo Ebola virus" (PDF). World Health Organization. Retrieved 22 May 2018. "Ebola virus disease - ... King JW (2008-04-02). "Ebola Virus". eMedicine. WebMD. Retrieved 2008-10-06. "Ebola virus disease". Retrieved 2014-08-15. ... CDC.gov The Ebola Virus 3D model of the Ebola virus, prepared by Visual Science, Moscow. ICTV Files and Discussions - ...
"Ebola Virus Disease Democratic Republic of Congo" (PDF). WHO. Retrieved 14 June 2017. "About Ebola Virus Disease". www.cdc.gov ... "Five Ebola virus patients in DR Congo reported dead: WHO". BERNAMA. 25 May 2022. Retrieved 13 June 2022. "5 Ebola virus ... "Democratic Republic of the Congo Ebola virus" (PDF). World Health Organization. Retrieved 22 May 2018. "Ebola virus disease - ... Équateur province Democratic Republic of the Congo Ebola virus outbreak 2018 Kivu Democratic Republic of the Congo Ebola virus ...
Ebola-chan Ebola virus epidemic in West Africa "Ebola virus disease, West Africa - update 3 July 2014". WHO. Archived from the ... The Ebola virus epidemic in West Africa has had a large effect on the culture of most of the West African countries. In most ... As the Ebola virus epidemic in West Africa developed in 2014, a number of popular self-published and well-reviewed books ... The severe Ebola virus disease epidemic occurring in West Africa likely stems from a single zoonotic transmission event ...
2018 DRC Ebola virus outbreak could mean: 2018 Équateur province Ebola outbreak 2018 Kivu Ebola outbreak This disambiguation ... page lists articles associated with the title 2018 Democratic Republic of the Congo Ebola virus disease outbreak. If an ...
Thus Ebola virus disease spread for several months before it was recognized as such. In late October 2014, the boy was later ... Feb 1999). "Ebola Virus Outbreak among Wild Chimpanzees Living in a Rain Forest of Côte d'Ivoire". J. Infect. Dis. 179 (s1): ... "Ebola virus disease, West Africa (Situation as of 27 May 2014)". WHO. Archived from the original on 25 October 2014. Retrieved ... "Ebola virus disease, West Africa (Situation as of 1 April 2014)". WHO. Archived from the original on 6 April 2014. Retrieved 18 ...
"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment". Science. 347 ( ...
Ebola virus disease, one of the infections with the highest lethality, has a CFR as high as 90%. Naegleriasis (also known as ... King, John W (April 2, 2008). "Ebola Virus". eMedicine. WebMd. Retrieved 2008-10-06. "Rabies Fact Sheet N°99". World Health ...
Ebolavirus enter cells through micropinocytosis with endosomal vesicles. After entrance into the endosomal vesicle, Ebolavirus ... "Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment". Science. 347 ( ... normal functioning of TPCs allows the Ebolavirus to escape. Therefore, when TPCs are not functioning, the Ebolavirus cannot ... The Ebolavirus takes advantage of host cell endocytotic membrane trafficking, leaving TPCs as a potential drug target. ...
August 26 - The Ebola virus first emerges in outbreaks of viral hemorrhagic fever in Yambuku, Zaire, followed by outbreaks in ... Bennett, D.; Brown, D. (May 1995). "Ebola virus". British Medical Journal (Clinical Research Ed.). 310 (6991): 1344-1345. doi: ...
Formenty, Pierre (2014). "Ebola Virus Disease". Emerging Infectious Diseases. Amsterdam: Academic Press. pp. 121-134. doi: ...
Malvy, Denis; McElroy, Anita K; de Clerck, Hilde; Günther, Stephan; van Griensven, Johan (March 2019). "Ebola virus disease". ...
"Ebola Virus Disease." WHO. N.p., n.d. Web. 19 September 2014. Hayes, C. G.; Burans, J. P.; Ksiazek, T. G.; Del Rosario, R. A.; ... "Update on the Ebola virus disease in DRC, No. 5, 30 August 2014". UN Office for the Coordination of Humanitarian Affairs. 30 ... "Five Ebola virus patients in DR Congo reported dead: WHO". Bernama. 25 May 2022. Retrieved 26 May 2022. "The Democratic ... "Ebola Virus Disease Outbreak Uganda Situation Reports" (PDF). WHO.Afro.int. WHO. Retrieved 18 June 2019. Editorial, Reuters ( ...
"Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus ... Ebola virus disease was discovered in 1976 when two consecutive outbreaks of fatal hemorrhagic fever occurred in different ... February 2020). "Ebola virus disease". Nature Reviews. Disease Primers. 6 (1): 13. doi:10.1038/s41572-020-0147-3. PMC 7223853. ... August 2015). "The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States". ...
"Ebola (Ebola virus disease)". Centers for Disease Control and Prevention. August 3, 2018. Archived from the original on March ... "Ebola virus disease". World Health Organization. Archived from the original on December 14, 2014. Retrieved August 24, 2022. " ...
"Ebola virus disease". www.who.int. Retrieved 2019-03-06. Center for Disease Prevention and Control. "B Virus (herpes B, monkey ... Ebola Virus is a rare infectious disease that is transmitted from wild animals (chimpanzees, monkeys, gorillas, fruit bats, etc ...
A virus of the genus Ebolavirus is a member of the species Bundibugyo ebolavirus if: it is endemic in Uganda it has a genome ... and the taxonomic suffix ebolavirus (which denotes an ebolavirus species). Bundibugyo virus (abbreviated BDBV) was first ... The species Bundibugyo ebolavirus is a virological taxon (i.e. a man-made concept) that was suggested in 2008 to be included in ... The name Bundibugyo ebolavirus is derived from Bundibugyo (the name of the chief town of the Ugandan Bundibugyo District, where ...
Ebola virus disease is caused by four of six viruses classified in the genus Ebolavirus. Of the four disease-causing viruses, ... Scholia has a topic profile for Western African Ebola virus epidemic. Ebola virus epidemic in West Africa at Wikipedia's sister ... Clinical care for survivors of Ebola virus disease (PDF) (Report). WHO. 11 April 2016. Carod-Artal FJ (2015). "Post-Ebolavirus ... "Democratic Republic of Congo: Ebola Virus Disease - External Situation Report 17: Declaration of End of Ebola Virus Disease ...
Ebola virus epidemic in Sierra Leone Ebola virus epidemic in Liberia Ebola virus disease in Mali Ebola virus disease in Nigeria ... An epidemic of Ebola virus disease in Guinea from 2013 to 2016 represents the first ever outbreak of Ebola in a West African ... The epidemic, which began with the death of a two-year-old boy, was part of a larger Ebola virus epidemic in West Africa which ... "Ebola virus disease in Guinea (Situation as of 25 March 2014)". Archived from the original on 6 October 2014. Retrieved 22 ...
Ebola virus epidemic in West Africa Ebola virus epidemic in Guinea Ebola virus epidemic in Liberia Ebola virus disease in Mali ... Ebola virus disease in Nigeria Ebola virus disease Health in Sierra Leone List of Ebola patients 2014 Ebola Virus in West ... The labs helped to determine if a patient had been infected by the Ebola virus. At that time, it took as much as five days to ... An Ebola virus epidemic in Sierra Leone occurred in 2014, along with the neighbouring countries of Guinea and Liberia. At the ...
"Ebola virus disease, West Africa - update 25 July 2014". WHO: Outbreak news. 25 July 2014. Archived from the original on 22 ... "Ebola virus disease, West Africa - update 28 August 2014". WHO. 28 August 2014. Archived from the original on 1 September 2014 ... "Ebola virus: PM calls on European Council for action". Prime Minister's Office. 18 October 2014. Retrieved 18 October 2014. "UK ... "Ebola virus disease update news 4 August 2014". World Health Organization. Archived from the original on August 4, 2014. ...
The 2018 Democratic Republic of the Congo Ebola virus outbreaks are instances where an outbreak of the Ebola virus has occurred ... Équateur province Democratic Republic of the Congo Ebola virus outbreak 2018 Kivu Democratic Republic of the Congo Ebola virus ...
"Ebola Virus". Center for Disaster Philanthropy. Retrieved April 19, 2019. Garland, Max. "Here's how FedEx is responding to the ...
Sudan ebolavirus, Taï Forest ebolavirus (originally Côte dIvoire ebolavirus), Zaire ebolavirus, and Bombali ebolavirus. The ... Each species of the genus Ebolavirus has one member virus, and four of these cause Ebola virus disease (EVD) in humans, a type ... The genus Ebolavirus (/iˈboʊlə/- or /əˈboʊləˌvaɪrəs/; ee-BOH-lə- or ə-BOH-lə-VY-rəs) is a virological taxon included in the ... The name Ebolavirus is derived from the Ebola River in Zaire (now the Democratic Republic of the Congo), near the location of ...
ERVEBO vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus. ... Guidance for Decontamination and Removal of Ebolavirus-Contaminated Waste for U.S. Residence ... or a sick or dead person infected with an ebolavirus. Learn more about Ebola disease. ...
ERVEBO vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus. ... Guidance for Decontamination and Removal of Ebolavirus-Contaminated Waste for U.S. Residence ... or a sick or dead person infected with an ebolavirus. Learn more about Ebola disease. ...
This article is about Ebola virus cases in the United States starting in 2014. For the 2013-2016 outbreak in Africa, see Ebola ... "Patient admitted with Ebola virus disease discharged from NIH Clinical Center". National Institutes of Health (NIH). July 20, ... Main article: Ebola virus disease treatment research. There is as yet no medication for Ebola approved by the U.S. Food and ... Thomas Eric Duncan was from Monrovia, Liberia, to date the country hit hardest by the Ebola virus epidemic.[19] Duncan worked ...
... Medically reviewed by the Healthline Medical Network - By Rachel Nall, MSN, CRNA - Updated on ... The Ebola virus does not have a cure or vaccine at this time. Instead, measures are taken to keep the person as comfortable as ... Although the Ebola virus has been present for more than 35 years, the largest outbreak began in West Africa in March 2014. This ... The Ebola virus likely originated in African fruit bats. The virus is known as a zoonotic virus because its transmitted to ...
Ebola Virus Infection in Imported Primates -- Virginia, 1989 In late November 1989, Ebola virus was isolated from cynomolgus ... Before this incident, no monkey had ever been found to be naturally infected with Ebola virus. The incubation period for Ebola ... Editorial Note: Unlike SHF virus, which does not cause clinical illness in humans, Ebola virus can cause severe disease in ... The ecology, natural history, and mode of transmission in nature of Ebola virus and the related Marburg virus are unknown. ...
New Ebolavirus Vaccine Design Seeks to Drive Stronger Antibody Defense. May 12, 2021 Scientists have unveiled a new Ebola virus ... Scientists Discover How Ebola Virus Infects Cells. Date:. April 19, 2005. Source:. NIH/National Institute of Allergy and ... Ebola virus, like the Marburg virus now alarming Angola, is a filovirus, a family of viruses that cause severe and frequently ... "Scientists Discover How Ebola Virus Infects Cells." ScienceDaily. www.sciencedaily.com. /. releases. /. 2005. /. 04. /. ...
Ebola virus disease (EVD), Ebola hemorrhagic fever (EHF) or simply Ebola is a disease of humans and other mammals caused by an ... It has been suggested that Ebola virus epidemic in West Africa be merged into this article or section. (Discuss) ... ebolavirus.[1] Symptoms start two days to three weeks after contracting the virus, with a fever, sore throat, muscle pain, and ... Retrieved from "https://en.wikiquote.org/w/index.php?title=Ebola_virus_disease&oldid=2811039" ...
Sudan ebolavirus, Zaire ebolavirus, Tai Forest (Ivory Coast) ebolavirus, Reston ebolavirus, and Bundibugyo ebolavirus. [1] The ... Tai Forest ebolavirus (formerly and perhaps still more commonly Ivory Coast ebolavirus or Côte dIvoire ebolavirus) ... Ebola virus is one of at least 30 known viruses capable of causing viral hemorrhagic fever syndrome. The genus Ebolavirus ... The fifth Ebolavirus species, also of African lineage, is Bundibugyo ebolavirus, which caused an outbreak in Uganda in 2007 to ...
... Protein Sci. 2014 Nov;23(11):1519-27. doi: 10.1002/pro.2541. Epub ... Here we review the different conformational states of the Ebola virus (EBOV) matrix protein VP40 that range from monomers, to ...
encoded search term (Ebola Virus Infection) and Ebola Virus Infection What to Read Next on Medscape ... Table 2. History of Zaire Ebola Virus Outbreaks. *Table 3. History of Tai Forest (Ivory Coast, Côte-dIvoire) Ebola Virus ... Ebola Virus Infection Clinical Presentation. Updated: Aug 08, 2023 * Author: John W King, MD; Chief Editor: Pranatharthi Haran ... Reemerging Sudan ebola virus disease in Uganda, 2011. Emerg Infect Dis. 2012 Sep. 18(9):1480-3. [QxMD MEDLINE Link]. [Full Text ...
How does Ebola virus spread? The WHO says it is believed that fruit bats may be the natural host of the Ebola virus in Africa, ... The Ebola virus causes viral hemorrhagic fever, which according to the U.S. Centers for Disease Control and Prevention (CDC), ... "The Ebola virus spreads through direct contact with the blood, secretions, or other body fluids of ill people, and indirect ... Finally, Reston Ebola is named after Reston in the U.S. state of Virginia, where this fifth strain of the Ebola virus was ...
ERVEBO vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus. ... Guidance for Decontamination and Removal of Ebolavirus-Contaminated Waste for U.S. Residence ... or a sick or dead person infected with an ebolavirus. Learn more about Ebola disease. ...
Ebola Virus: New Aid Worker Attack In Sierra Leone Amid Curfew. By Matt Schiavenza @MattSchiavenza 09/20/14 AT 5:10 PM EDT. ... came under attack Saturday while attempting to bury five victims of the deadly Ebola virus disease, according to a police ...
USEbola virusUganda. Join our commenting forum. Join thought-provoking conversations, follow other Independent readers and see ... US to screen Uganda passengers for Ebola virus as cases surge. The screenings have been ordered by the director of the Centers ... The United States will begin screening passengers travelling from Uganda for the Ebola virus as it surges in the African ... US to screen Uganda passengers for Ebola virus as cases surge. Doctors walk inside the Ebola isolation section of Mubende ...
Other members of the filovirus family are the five species of ebolavirus. Filoviruses … ...
Ebola Virus Disease. Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have ... India on Alert for Deadly Ebola Virus. The Indian government opened an emergency helpline on Saturday and put the countrys ... An American Liberian who arrived Lagos from Monrovia, capital of Liberia, via Lome (Togo), eventually died of Ebola virus in a ... Gambian National Airline Suspended by Nigeria Over Ebola Virus Personalised Printable Document (PDF). Please complete this form ...
A team of researchers has identified a cellular protein that acts as a receptor for Ebola virus and Marburg virus. Furthermore ... Maury noted that these locations are consistent with some of the ways the Ebola virus is thought to be transmitted -- ... at University of Texas Medical Branch verified that the ARD5 antibody blocks infection by infectious Zaire Ebola Virus in cells ...
It is lethal folly to ignore these numbers in establishing immigration policy, just as it is lethal folly to ignore the Ebola virus ... Islamic fundamentalism is the Ebola virus of culture. It is dangerous, contagious and fatal to any society, culture or nation ...
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J. Infect. Dis. 2007, ... Azotemia, detected as increased BUN and/or CRE, may be caused by pre-renal and/or renal conditions [22]. In Ebola virus ... Figure 1. Serum BUN responses in rhesus monkeys exposed to Ebola virus. Symbols represent the maximal serum BUN value obtained ... Figure 1. Serum BUN responses in rhesus monkeys exposed to Ebola virus. Symbols represent the maximal serum BUN value obtained ...
"Ebola virus disease and palliative care in humanitarian crises" The Lancet Vol. 393 Iss. 10176 (2019) p. 1100 Available at: ...
Background The nucleotide analogue brincidofovir was developed to prevent and treat infections caused by double-stranded DNA viruses. Based on in vitro data suggesting an antiviral effect against Ebola virus, brincidofovir was included in the World Health Organisation list of agents that should be prioritised for clinical evaluation in patients with Ebola virus disease (EVD) during the West African epidemic. Methods and Findings In this single-arm phase 2 trial conducted in Liberia, patients with laboratory-confirmed EVD (two months of age or older, enrolment bodyweight ≥50 kg) received oral brincidofovir 200 mg as a loading dose on day 0, followed by 100 mg brincidofovir on days 3, 7, 10, and 14. Bodyweight-adjusted dosing was used for patients weighing |50 kg at enrolment. The primary outcome was survival at Day 14 after the first dose of brincidofovir. Four patients were enrolled between 01 January 2015 and 31 January 2015. The trial was stopped following the decision by the manufacturer ...
A new Ebola virus has been found in bats in Sierra Leone, two years after the end of an outbreak that killed over 11,000 across ... At this time, it is not yet known if the Bombali Ebola virus has been transmitted to people or if it causes disease in people ...
The truth behind the Ebola virus. The Ebola virus is a minor sickness that was first discovered on the continent of Africa. You ... Because of one of the unsung benefits of the Ebola virus. Yes, the wildly powerful fever keeps Joey warm all winter long or for ... Its Paula, who is lucky enough to have the Ebola virus and live inside this fancy plastic bubble. Whats that, you say? It ... Say hello to Mary, she has the Ebola virus and loves it. Why? Well, have you heard motivational speakers talk about living ...
ICAO have added a new web page dedicated to the Ebola Virus Disease outbreak on the CAPSCA web site (http://www.capsca.org/ ...
... February 7, 2016. Lauren Santye, Assistant Editor ...
Ebolavirus VP30 The Ebola virus is the causative agent for Ebola hemorrhagic disease in humans and in other mammals. Since 1976 ... This work was published in the Journal Acta Crystallographica Section F. Reference: Structure of the Reston ebolavirus VP30 C- ...
... (PDF) ... Healthcare Professionals Who Volunteer to Fight the Ebola Virus Overseas Policy and Procedure - New York ... Healthcare Professionals Who Volunteer to Fight the Ebola Virus Overseas Policy and Procedure - New York ... means to serve as a healthcare professional in a country classified as having widespread transmission of the Ebola virus ...
Ebola Virus Disease (EVD). On January 11, 2023 CDC and the Government of Uganda announced the end of the Ebola outbreak in ... Ebola Virus Disease (EVD) is a rare and deadly disease. The viruses that cause EVD are found mainly in countries located in ...
  • There are currently two treatments* approved by the U.S. Food and Drug Administration (FDA) to treat EVD caused by the Ebola virus, species Zaire ebolavirus , in adults and children. (cdc.gov)
  • Neither Inmazeb™ nor Ebanga™ have been evaluated for efficacy against species other than Zaire ebolavirus . (cdc.gov)
  • ERVEBO vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus. (cdc.gov)
  • In 2019, the country experienced an outbreak of Zaire ebolavirus. (who.int)
  • The six known virus species are named for the region where each was originally identified: Bundibugyo ebolavirus, Reston ebolavirus, Sudan ebolavirus, Taï Forest ebolavirus (originally Côte d'Ivoire ebolavirus), Zaire ebolavirus, and Bombali ebolavirus. (wikipedia.org)
  • Zaire ebolavirus has the highest mortality rate of the ebolaviruses and is responsible for the largest number of outbreaks of the six known species of the genus, including the 1976 Zaire outbreak and the outbreak with the most deaths (2014). (wikipedia.org)
  • The name Ebolavirus is derived from the Ebola River in Zaire (now the Democratic Republic of the Congo), near the location of the 1976 outbreak, and the taxonomic suffix -virus (denoting a viral genus). (wikipedia.org)
  • As the epidemic of Zaire ebolavirus in Western Africa continues (1,779 cases and 961 deaths in four countries), many are questioning why there are no means of preventing or stopping infection. (virology.ws)
  • CusabioAlternative Name(s): GP1,2 ;GPGene Names: GPResearch Areas: OthersOrganism: Zaire ebolavirus (strain. (joplink.net)
  • CusabioAlternative Name(s): Ebola VP24 (eVP24)Gene Names: VP24Research Areas: OthersOrganism: Zaire ebolavirus. (joplink.net)
  • The emergence of Zaire ebolavirus in West Africa and the scope of the 2014-2016 Ebola virus disease (EVD) epidemic have come as a surprise in a region not previously known to harbor Ebola virus. (netce.com)
  • Vaccines that display the Zaire ebolavirus glycoprotein spike complex are a prime component for the effort to combat it. (uni-koeln.de)
  • In December 2013, transmission of Zaire ebolavirus (Ebola virus (EBOV)) to humans occurred in southeastern Guinea [ 1 ], spreading to Liberia and Sierra Leone and rapidly surpassing the cumulative total of previous Ebola virus disease (EVD) outbreaks [ 2 , 3 ]. (biomedcentral.com)
  • Available at https://www.who.int/csr/don/19-september-2019-ebola-drc/en/ . (medscape.com)
  • Brazzaville/Kampala - The health authorities in Uganda today declared an outbreak of Ebola after a case of the Sudan ebolavirus was confirmed in Mubende district in the central part of the country. (who.int)
  • Each species of the genus Ebolavirus has one member virus, and four of these cause Ebola virus disease (EVD) in humans, a type of hemorrhagic fever having a very high case fatality rate. (wikipedia.org)
  • Although Ebola disease is rare, people can get the disease through contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with an ebolavirus. (cdc.gov)
  • In September 2022, Uganda reported a case of Ebola disease caused by the Sudan ebolavirus, the first in a decade. (msdmanuals.com)
  • Ebola virus disease (EVD) is a severe, often fatal, zoonotic infection caused by a virus of the Filoviridae family (genus Ebolavirus )" [1] . (physio-pedia.com)
  • The virus family Filoviridae includes three genera: Cuevavirus, Marburgvirus, and Ebolavirus. (who.int)
  • Ebolavirus is a genus of ssRNA- viruses in the family Filoviridae that infect mammals. (expasy.org)
  • Reston ebolavirus (RESTV) should be considered a livestock pathogen with potential to affect other mammals, including people, according to National Institutes of Health scientists. (nih.gov)
  • The Ebolavirus (EBOV) glycoprotein (GP) is essential for the attachment and fusion of virus and host cell membranes. (wyatt.com)
  • Ebolavirus (EBOV) is a highly virulent pathogen capable of causing a severe hemorrhagic fever with 50-90% lethality. (biologicmodels.com)
  • Ebolavirus infection in humans leads to fatal hemorrhagic fever. (expasy.org)
  • In 2002, the name was changed to Ebolavirus and in 2010, the genus was emended. (wikipedia.org)
  • Our study rationalizes the selection of the V(H)3-15/V(lambda)1-40 germline genes for specifically targeting this site and highlights Ebolavirus species-specific sequence divergences that may restrict breadth of V(H)3-15/V(lambda)1-40-based humoral response. (uni-koeln.de)
  • The results from this study could help develop improved immunization schemes and further enable the design of immunogens that would be efficacious against a broader set of Ebolavirus species. (uni-koeln.de)
  • Ebolavirus is a filamentous, enveloped virus within the order Mononegavirales which also contains rabies and measles viruses. (wikipedia.org)
  • Of the five known strains, the Sudan Ebolavirus (SUDV) has caused five different outbreaks including the second largest outbreak between 2000 and 2001. (nih.gov)
  • This is the first time in more than a decade that Uganda is recording an outbreak of Sudan ebolavirus. (who.int)
  • There have been seven previous outbreaks of the Sudan ebolavirus, with four occurring in Uganda and three in Sudan. (who.int)
  • Uganda last reported an outbreak of Sudan ebolavirus in 2012. (who.int)
  • On this episode of TWiV we discuss unusual properties of monoclonal antibodies: one that that binds the receptor attachment site and blocks infection with all three poliovirus serotypes, and others that inhibit Ebolavirus spread from cell to cell. (asm.org)
  • They discovered that Ebolavirus uses macropinocytosis to enter the host cells. (wikipedia.org)
  • Also, blocking the macropinocytosis pathway has been proven to stop Ebolavirus from entering the cells. (wikipedia.org)
  • Filamentous 970 nm long for Ebolavirus. (expasy.org)
  • The bats show no symptoms of the disease, indicating that they may be the main natural reservoirs of the Ebolavirus. (wikipedia.org)
  • The Bombali ebolavirus (BOMV) was isolated from the little free-tailed bat (Chaerephon pumilus) and the Angolan free-tailed bat (Mops condylurus) in Sierra Leone. (wikipedia.org)
  • I spoke with virologist Ian Goodfellow, whose laboratory works on noroviruses, about why he went to Sierra Leone to establish an Ebolavirus diagnostic and sequencing laboratory. (virology.ws)
  • This discovery was proven by the fact that Ebolavirus co-localizes with sorting nexin 5 (SNX5), which consists of a large family of peripheral membrane proteins that associate with newly formed macropinosomes. (wikipedia.org)

No images available that match "ebolavirus"